Markets:

Overview

News

Currencies

International

Treasuries

Cellectar Biosciences, Inc. - Common Stock (NQ:CLRB)

2.820 +0.050 (+1.81%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cellectar Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Cancer-Focused Cellectar Biosciences Stock Trades Lower Despite Meeting Goal In Blood Cancer Study ↗

July 23, 2024

Cellectar Biosciences stock drops 19.2% following the release of CLOVER WaM study results. The pivotal study for iopofosine I 131 in relapsed/refractory Waldenstrom's macroglobulinemia showed an 80%...

Via Benzinga

CLRB Stock Earnings: Cellectar Biosciences Misses EPS for Q1 2024 ↗

May 14, 2024

CLRB stock results show that Cellectar Biosciences missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Hedgeye Warns That Reddit (RDDT) Stock Will Fall 50% ↗

March 27, 2024

Reddit stock is a hot topic among traders on Wednesday after one analyst warns that RDDT could give up 50% of its gains.

Via InvestorPlace

Why Is Gamida Cell (GMDA) Stock Down 82% Today? ↗

March 27, 2024

Gamida Cell stock is falling on Wednesday with heavy trading of GMDA shares after the company announced plans to go private.

Via InvestorPlace

CLRB Stock Earnings: Cellectar Biosciences Beats EPS for Q4 2023 ↗

March 27, 2024

CLRB stock results show that Cellectar Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Earnings Preview For Cellectar Biosciences ↗

March 26, 2024

Via Benzinga

Recap: Cellectar Biosciences Q1 Earnings ↗

May 04, 2023

Via Benzinga

Recap: Cellectar Biosciences Q3 Earnings ↗

November 03, 2022

Cellectar Biosciences (NASDAQ:CLRB) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Cellectar Biosciences: Q2 Earnings Insights ↗

August 05, 2022

Cellectar Biosciences (NASDAQ:CLRB) reported its Q2 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For March 27, 2024 ↗

March 27, 2024

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.

Via Benzinga

Cellectar Biosciences Is An 'Attractive Acquisition Target' According To This Analyst - Here's Why ↗

March 04, 2024

Cellectar Biosciences reports positive Phase 1 trial results for iopofosine I 131 in head and neck squamous cell carcinoma, achieving 64% complete remission and 73% overall response rate. Roth Capital...

Via Benzinga

Why Is Cancer-Focused Cellectar Biosciences Stock Trading Higher Today? ↗

January 08, 2024

Cellectar Biosciences Inc (NASDAQ: CLRB) announced data from its CLOVER WaM pivotal study, evaluating iopofosine I 131, a targeted radiotherapy candidate for the treatment of relapsed/refractory...

Via Benzinga

Wells Fargo Is Warming Up to Enphase Energy (ENPH) Stock ↗

January 08, 2024

Enphase Energy stock is rising higher on Monday as investors react to a new upgrade and increased price target for ENPH from Wells Fargo.

Via InvestorPlace

Why Is Spirit AeroSystems (SPR) Stock Down 14% Today? ↗

January 08, 2024

Spirit AeroSystems stock is falling hard on Monday as investors in SPR react to one of the company's flights experiencing a mid-air blowout.

Via InvestorPlace

Why Is LumiraDx (LMDX) Stock Down 13% Today? ↗

January 08, 2024

LumiraDx stock is falling hard on Monday as investors in LMDX prepare for the company's shares to be delisted on Tuesday!

Via InvestorPlace

Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today? ↗

January 08, 2024

Cellectar Biosciences stock is up on Monday as investors celebrate positive study results with heavy trading of CLRB stock this morning.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 08, 2024

It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 22, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 06, 2023

Via Benzinga

Crude Oil Rises 1%; Verb Technology Shares Spike Higher ↗

September 05, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling 100 points on Tuesday. The Dow traded down 0.31% to 34,728.66 while the NASDAQ rose 0.11% to 14,047.61. The S&P...

Via Benzinga

Topics Stocks

Nasdaq Turns Higher; US Factory Orders Fall 2.1% In July ↗

September 05, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.15% to 34,785.92 while the NASDAQ rose 0.12% to 14,048.20. The S&P 500, also...

Via Benzinga

Topics Stocks

Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 05, 2023

Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform...

Via Benzinga

Cellectar Biosciences Inc. (NASDAQ: CLRB) Near Top of Volume Charts in Tuesday Trading

September 05, 2023

Via Investor Brand Network

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 23, 2022

Via Benzinga

Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket ↗

August 23, 2022

Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss.

Via Benzinga

Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session ↗

July 25, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.

Via Benzinga

Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday ↗

July 26, 2022

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.

Via Benzinga

Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset ↗

July 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.